Cargando…

Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the highly contagious agent responsible for the coronavirus disease 2019 (COVID-19) pandemic. An essential requirement for understanding SARS-CoV-2 biology and the impact of antiviral therapeutics is a robust method to detect the presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiem, Kevin, Park, Jun-Gyu, Morales Vasquez, Desarey, Plemper, Richard K., Torrelles, Jordi B., Kobie, James J., Walter, Mark R., Ye, Chengjin, Martinez-Sobrido, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603146/ https://www.ncbi.nlm.nih.gov/pubmed/35980204 http://dx.doi.org/10.1128/spectrum.02379-22

Ejemplares similares

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
por: Ye, Chengjin, et al.
Publicado: (2021)

Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
por: Chiem, Kevin, et al.
Publicado: (2021)

A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
por: Ye, Chengjin, et al.
Publicado: (2023)

Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening
por: Gorshkov, Kirill, et al.
Publicado: (2022)

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
por: Gorshkov, Kirill, et al.
Publicado: (2021)

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice
por: Silvas, Jesus A., et al.
Publicado: (2021)

Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome
por: Ye, Chengjin, et al.
Publicado: (2020)

Rapid Generation of Circulating and Mucosal Decoy Human ACE2 using mRNA Nanotherapeutics for the Potential Treatment of SARS‐CoV‐2
por: Kim, Jeonghwan, et al.
Publicado: (2022)

Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes
por: Ye, Chengjin, et al.
Publicado: (2022)

Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections
por: Martinez-Sobrido, Luis, et al.
Publicado: (2023)

Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric Materials
por: Guerrero-Arguero, Israel, et al.
Publicado: (2023)

Identification of In Vitro Inhibitors of Monkeypox Replication
por: Chiem, Kevin, et al.
Publicado: (2023)

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
por: Piepenbrink, Michael S., et al.
Publicado: (2021)

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy
por: Horspool, Alexander M., et al.
Publicado: (2021)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
por: Deshpande, Ashlesha, et al.
Publicado: (2021)

A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs
por: Park, Jun-Gyu, et al.
Publicado: (2020)

In vivo rescue of recombinant Zika virus from an infectious cDNA clone and its implications in vaccine development
por: Ávila-Pérez, Gines, et al.
Publicado: (2020)

Identification of Inhibitors of ZIKV Replication
por: Morales Vasquez, Desarey, et al.
Publicado: (2020)

Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice
por: Wong, Ting Y., et al.
Publicado: (2022)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development
por: Lorenzo, María M., et al.
Publicado: (2022)

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
por: Lorenzo, María M., et al.
Publicado: (2023)

Amino Acid Residues Involved in Inhibition of Host Gene Expression by Influenza A/Brevig Mission/1/1918 PA-X
por: Chiem, Kevin, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
por: Au, Wing Ying, et al.
Publicado: (2022)

Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
por: Cox, Robert M., et al.
Publicado: (2021)

Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
por: Hilimire, Thomas A., et al.
Publicado: (2020)

SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming
por: Wu, Chien-Ting, et al.
Publicado: (2023)

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics
por: Veleanu, Andrei, et al.
Publicado: (2022)

Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
por: Plante, Kenneth S., et al.
Publicado: (2021)

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
por: White, Chantelle L., et al.
Publicado: (2021)

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication
por: Sourimant, Julien, et al.
Publicado: (2021)

Bi-Reporter Vaccinia Virus for Tracking Viral Infections In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
por: Zarkoob, Hoda, et al.
Publicado: (2021)

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
por: Oladunni, Fatai S., et al.
Publicado: (2020)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v6bpbo00461re3n7n95iq4eiee